Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "End-Period-Cash-Flow" stands at -1.52 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 03/31/2025.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.3824 Billion Hong Kong Dollars compared to the value the year prior.
The 1 year change is -0.3824 Billion Hong Kong Dollars.
The 3 year change is -1.32 Billion Hong Kong Dollars.
The 5 year change is -4.18 Billion Hong Kong Dollars.
The 10 year change is -3.84 Billion Hong Kong Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - End Period Cash Flow | 905,699,262,464.00 |
![]() | Johnson & Johnson - End Period Cash Flow | 486,508,953,600.00 |
![]() | AbbVie Inc - End Period Cash Flow | 399,570,305,024.00 |
![]() | Roche Holding AG - End Period Cash Flow | 317,433,206,677.55 |
![]() | AstraZeneca PLC - End Period Cash Flow | 280,205,508,085.11 |